PVP Ventures Q1 FY27 Results (NSE: PVP)

14 Aug 2026 · Analysis by Alpha Inflection

Signal: Margins at cyclical peak

The read

The quarter marks a consolidated revenue acceleration to ₹4,563.69 lakh, +165.2% YoY, but the earnings inflection is low quality: ₹2,583.01 lakh other income and a ₹1,085.00 lakh HHT impairment dominated PAT, while the reported operating EBITDA margin contracted 2014bps YoY to 70.86%; standalone profit of ₹1,511.16 lakh exceeded consolidated PAT of ₹1,106.31 lakh because subsidiaries and non-controlling interests diluted group earnings.

P&L walk

Consolidated revenue increased to ₹4,563.69 lakh, +165.2% YoY and +10.1% QoQ, while the reported 70.86% operating EBITDA margin contracted 2014bps YoY and 144bps QoQ; PAT was supported by ₹2,583.01 lakh of other income despite a ₹1,085.00 lakh impairment.

Key positives

• Consolidated revenue reached ₹4,563.69 lakh, +165.2% YoY and +10.1% QoQ, extending the sharp revenue recovery visible in the recent quarterly series.
• Consolidated PAT turned positive at ₹1,106.31 lakh from a ₹11.49 lakh loss YoY, and owner-attributable PAT was ₹1,208.22 lakh versus ₹28.86 lakh.
• The company increased its 7 Med India stake by 7.99 percentage points to 41.23% for ₹1,926.24 lakh, expanding its healthcare exposure.

Key concerns

• Operating EBITDA margin fell to 70.86% from 91.00% YoY and 72.30% QoQ, reversing the prior-quarter margin expansion trend.
• Gross margin compressed approximately 1307bps YoY as cost of materials rose to 19.69% of revenue from 3.80%; the filing does not disclose the cause.
• Finance cost increased 22.6% YoY to ₹1,014.32 lakh and interest coverage was only 0.66x, indicating continuing balance-sheet pressure.
• Consolidated PAT of ₹1,106.31 lakh was below standalone PAT of ₹1,511.16 lakh, with non-controlling interests reporting a ₹101.91 lakh loss.

View original filing

Research and educational content only. Not investment advice.